Table 1 Characteristics of study population by HAART status in Hawassa, Southern Ethiopia
Variables | HAART group (n=113) | pre-HAART group (n=113) |
|---|---|---|
Gender = Female, n (%) | 75 (66.4) | 72 (63.7) |
Male, n (%) | 38 (33.6) | 41 (36.3) |
Age, (years), mean ± SD | 37.2 ( 8.7) | 33.7 (8.3)** |
18–30 years, n (%) | 26 (23) | 49 (43.4) |
31–40 years, n (%) | 59 (52.2) | 47(41.6) |
41–50 years, n (%) | 21 (18.6) | 12 (10.6) |
>50 years, n (%) | 7 (6.2) | 5 (4.4) |
BMI (Kg/m2), mean ± SD | 22.3 (4.1) | 21.5 ( 3.9) |
<18 Kg/m2, n (%) | 8 (7) | 14 (12.4) |
18–25 Kg/m2, n (%) | 82 (72.6) | 84 (74.3) |
>25 Kg/m2, n (%) | 23 (20.4) | 15 (13.3) |
CD4+ count (cells/mm3), mean ± SD | 460 (221) | 356 (216.7) *** |
< 200 cells/mm3, n (%) | 16 (14.2) | 29 (25.7) |
200–400 cells/mm3, n (%) | 32 (28.3) | 44 (38.9) |
> 400 cells/mm3, n (%) | 65 (57.5) | 40 (35.4) |
Duration of HAART, mean ±SD | 49.4 (16.5) | -- |
12–24 months, n (%) | 10 (8.8) | -- |
24–36 months, n (%) | 18 (15.9) | -- |
36–48 months, n (%) | 27 (23.9) | -- |
48–60 months, n (%) | 24 (21.2) | -- |
> 60 years, n (%) | 34 (30.1) | -- |
Current anti-TB users, n (%) | 0 | 4 (3.5) |
Current smoking, n (%) | 6 (5.3) | 7 (6.2) |
Past smoking, n (%) | 15 (13.3) | 13 (11.5) |